Tricuspid Valve Geometry of Idiopathic Pulmonary Hypertension:a Three-dimensional Transthoracic Echocardiography Study / 中国循环杂志

Objectives:To evaluate the tricuspid valve(TV)geometric remodeling in patients with idiopathic pulmonary arterial hypertension(IPAH)by three-dimensional transthoracic echocardiography. Methods:Two-dimensional and three-dimensional transthoracic echocardiography were performed in 30 IPAH patients and 15 healthy controls,and the geometry parameters of TV were obtained by four-dimensional auto tricuspid valve quantitative(4D Auto-TVQ)in the right ventricular-focused apical view.Pulmonary arterial hypertension was determined by right heart catheterization within 48 hours of echocardiography. Results:The 4-chamber diameter,tricuspid annular(TA)perimeter,TA area,maximal tenting height,coaptation point height and tenting volume were larger in IPAH patients than those in healthy controls(all P＜0.05),2-chamber diameter was similar between two groups.In IPAH group,maximal tenting height and coaptation point height were moderately correlated with right ventricular end-diastolic volume(r=0.710,r=0.515,both P＜0.05),while TA perimeter,4-chamber diameter and TA area were moderately correlated with right atrial end-systolic volume(r=0.712,r=0.558,r=0.545,all P＜0.05). Conclusions:IPAH patients have larger maximal tenting height,coaptation point height and tenting volume,TA enlargement is mainly visible in 4-chamber diameter.TV tenting height is associated with right ventricular volume,but TA size is associated with right atrial volume in IPAH patients.

Retrasplante pulmonar con cross-match positivo en trasplante pulmonar primario complicado con rechazo mediado por anticuerpos / Lung Retransplantation with Positive Crossmatch in Primary Lung Transplantation Complicated by Antibody-Mediated Rejection

La hipertensión arterial pulmonar (HAP) representa el 2,6% de los trasplantes pulmonares (TP), con una mediana de supervivencia condi cional (desde los 30 días del TP) de 9,8 años. Son frecuentes, el rechazo celular agudo (ACR) y la disfunción crónica del injerto (CLAD), mientras que es infrecuente el rechazo mediado por anticuerpos (AMR). El retrasplante pulmonar (RTP) constituye el 4% del TP mundial, debido a complicaciones en la vía aérea, disfunción primaria del injerto, ACR y CLAD. Mujer de 22 años, portadora de HAP idiopática (HAPI) desde el año 2013, trasplantada bipulmonar (TBP) en enero de 2018. A los 16 meses presentó neumonía adquirida en la comuni dad. En una internación posterior, presentó ACR y a pesar de pulsos de metilprednisolona, progresó a requerimientos de cánula de alto flujo y ventilación mecánica no invasiva hospitalaria, caída del VEF1, y tomografía de tórax con vidrio esmerilado difuso y engrosamiento irregular reticular del intersticio subpleural; interpretándose como CLAD a predominio de síndrome de bronquiolitis obliterante (BOS), con presencia de anticuerpos específicos contra el donante (DSA). En enero de 2020 se realizó nuevo TP y ante cross-match positivo, se realizó plasmaféresis y reposición de IgG. Al mes del egreso, no se observaron signos de rechazo en control de biopsias transbronquiales. Entre 2 y 10% de los pacientes con indicación primaria de TP por HAPI son sometidos a retrasplante pulmonar (RTP). La presencia de DSA y el miss-match de HLA, no son contraindicaciones para el RTP.

Pulmonary arterial hypertension (PAH) represents 2.6% of lung transplantations (LT), with a conditional median survival (from 30 days after LT) of 9.8 years. Acute cellular rejection (ACR) and chronic lung allograft dysfunction (CLAD) are common; whereas the antibody-mediated rejection (AMR) is not. Lung retransplantation (LR) accounts for 4% of global LTs for complications in the airways, primary allograft dys function, ACR and CLAD. 22-year-old woman with idiopathic PAH (IPAH) since 2013, who underwent a double-lung transplantation (DLT) in January 2018. 16 months after transplantation she presented community-acquired pneumonia. During a subsequent hospitalization, she presented ACR. Despite the fact that she received pulse methylprednisolone, she required high-flow cannula therapy and hospital non-invasive mechanical ventilation; the FEV1 was reduced and she underwent a chest tomography with diffuse ground glass opacities and irregular reticular thickening of the subpleural interstitium; interpreting the predominance of BOS (bronchiolitis obliterans syndrome) as CLAD, with presence of donor-specific antibodies (DSA). In January 2020, she received a new DLT and due to a positive crossmatch, she was treated with plasmapheresis and IgG replacement. One month after hospital discharge, no signs of rejection were observed at the BTB (bone-patellar tendon-bone) control. Between 2 to 10% of patients with primary indication of LT for IPAH are subjected to lung retransplantation (LR). The presence of DSA and HLA (human leucocyte antigen) mismatch aren't contraindications to LR.

Conducción anestésica perioperatoria en gestante a término con hipertensión pulmonar idiopática / Perioperative anesthetic management in term pregnant women with idiopathic pulmonary hypertension

Introducción: La hipertensión arterial pulmonar es una enfermedad con una baja incidencia en la gestante, aunque trae consigo una alta mortalidad una vez presentada. Un diagnóstico oportuno y un manejo perioperatorio adecuado minimizan el riesgo de desenlace fatal tanto para la madre como el feto. Objetivo: Describir el comportamiento de la hipertensión arterial pulmonar en la gestante a término y su conducción anestésica. Presentación del caso: Paciente de 23 años, antecedentes de salud, edad gestacional de 35.2 semanas. Luego de presentar dolor de espalda y ardor en el pecho relacionado con el esfuerzo, palpitaciones, disnea y bloqueo de rama derecha en electrocardiograma, se ingresa en UTI con sospecha de tromboembolismo pulmonar, el cual queda descartado tras diagnóstico confirmatorio de hipertensión pulmonar después de realizar angio TAC y ecocardiografía. Se decide realizar cesárea programada bajo técnica regional peridural, sin complicaciones tanto para la madre como el niño. Después de 2 días bajo vigilancia intensiva se traslada a su centro hospitalario de cabecera. Conclusiones: La vía del parto, así como una elección adecuada de la técnica anestésica, puede ser la diferencia entre el éxito y la fatalidad. Las técnicas regionales suelen recomendarse por encima de la técnica de anestesia general siempre que no se presenten contraindicaciones(AU)

Introduction: Pulmonary arterial hypertension is a disease with low incidence in the pregnant woman, although it brings about high mortality once presented. Timely diagnosis and adequate perioeprative management minimize the risk of fatal outcome for both mother and fetus. Objective: To describe pulmonary arterial hypertension and its anesthetic management in the term pregnant woman. Case presentation: 23-year-old female patient, with health history and gestational age of 35.2 weeks. After presenting back pain and chest burning associated with exertion, palpitations, dyspnea and right bundle branch block in the electrocardiogram, the patient was admitted to the intensive care unit with suspected pulmonary thromboembolism, which was ruled out due to the confirmatory diagnosis of pulmonary hypertension after performing computerized tomography angiography and echocardiography. Scheduled cesarean section was decided to be perform using the regional peridural technique, without complications for both the mother and the child. After two days under intensive surveillance, she was transferred to her primary hospital. Conclusions: The route of delivery, as well as an adequate choice of the anesthetic technique, can be the difference between success and fatality. Regional techniques are usually recommended over the general anesthesia technique, as long as there are no contraindications(AU)

Pulmonary artery denervation to treat idiopathic pulmonary arterial hypertension in children:A case report and literature review / 中国实用儿科杂志

OBJECTIVE: To explore the safety and feasibility of pulmonary artery denervation(PADN)in children with idiopathic pulmonary hypertension(IPAH). METHODS: On July 11,2019,PADN was performed in Qingdao Women and Children's Hospital on the bifurcation of main pulmonary artery and the opening of left and right pulmonary artery in a child with IPAH. The pressure and resistance of pulmonary artery were monitored after operation. RESULTS: The pressure and resistance of pulmonary artery decreased significantly immediately after PADN. No serious complications occurred.CONCLUSION: PADN may be safe and feasible for children with IPAH. Further follow-up and multi-center registry study is necessary to confirm the efficacy and feasibility of PADN.

Lung transplantation with extracorporeal membrane oxygenation for idiopathic pulmonary arterial hypertension / 中华器官移植杂志

Objective To discuss the benefits of extracorporeal membrane oxygenation (ECMO) applied in the patients with idiopathic pulmonary arterial hypertension during the operation of bilateral sequential single lung transplantation.Methods Fifteen patients with idiopathic pulmonary arterial hypertension received lung transplantation supported with ECMO between Nov.2009 and Sep.2014.ECMO was removed after the transplantation if the oxygenation and hemodynamic were stable,otherwise,ECMO was applied continuously until the situation improved.Results All the operations of 15 patients were accomplished successfully and the ECMO was removed in 3 patients after the operation immediately,while in the other 12 patients,ECMO was applied continuously until the situation improved in ICU.ECMO was applied again in 3 patients when it was necessary.Deep venous thrombosis occurred in one patient.Three patients died after operation and the other 12 patients are alive till now.Conclusion ECMO can be applied safely and effectively in lung transplantations for idiopathic pulmonary arterial hypertension patients.

Serum HMGB1 Levels and Its Clinical Significance in Patients with Idiopathic Pulmonary Arterial Hypertension / 中山大学学报(医学科学版)

[Objective]To estimate the clinical value of serum high mobility group box 1(HMGB1) as a biomarker of idiopathic pulmonary arterial hypertension (IPAH).[Methods]This study included 33 patients with IPAH that were confirmed by right heart catheter in the Second Xiangya Hospital, Central South University from May 2011 to April 2015. 8 patients with IPAH were followed up for 6 months during treating with PAH-specific pharmacotherapies. All the subjects ' clinical data were collected,HMGB1 levels were determined by enzyme linked immunosorbent assay(ELISA).[Results]Serum HMGB1 levels (ng/mL) were significantly increased in patients with IPAH compared with the control group(14.8 ± 2.4 vs. 3.8 ± 1.2, P<0.001);The serum HMGB1 levels were significant?ly positive correlation with mean pulmonary arterial pressure(MPAP) and pulmonary vascular resistauce (PVR) ( r=0.864, P<0.001; r=0.460,P=0.002) in the patients with IPAH. After treating with PAH-specific pharmacotherapies for 6 month, HMGB1 levels(ng/mL) were significantly decreased(15.9±5.3 vs 11.1±2.5,P=0.021)along with the patients'MPAP(62.3±9.7 vs 54.0±8.7,mmHg)and 6-min walk distances(m)improved(368±69 vs 401±55,P<0.001).[Conclusions]Our study suggested that serum HMGB1 may be used as a biomarker of treatment response to targeted therapy, and it will be used as a biomarker in the follow-up evaluation of patients with IPAH.

Clinical features and prognostic factors in children with idiopathic pulmonary arterial hypertension / 中国小儿急救医学

Objective To investigate the clinical features and prognostic factors in children with idi-opathic pulmonary arterial hypertension(IPAH). Methods The data of children with IPAH diagnosed in Beijing Children′s Hospital from January 2006 to December 2015 were collected. The cases were divided into survival group and death group according to the prognosis. The risk factors influencing prognosis in children with IPAH were identified by Logistic regression analysis. Results Total 26 patients were enrolled in this study,and 17 of them survived and 9 of them were dead. IPAH was found to be more common in school-age children. The average age of the patients was(6. 6 ± 3. 6)years and the male to female ratio was 1. 17∶1. All of the children had the symptoms with decreased activity tolerance and fatigue. The incidence of syncope and dyspnea and edema of lower extremity were 34. 6%,23. 1%. Accentuated pulmonic second sound(P2) was detected in 92. 3% of patients during physical examination, which was also the most common sign. About 50. 0% patients were functional class Ⅲ-Ⅳ. Echocardiography showed that all childrens′ mean pulmonary artery systolic pressure(PASP) was(79. 0 ± 20. 3) mmHg(1 mmHg=0. 133 kPa) and 16 of them with right ventricular dilatation. Electrocardiogram with ST-T changes and right ventricular high voltage were common. The average plasma level of brain natriuretic peptide(BNP) in all cases was(870. 4 ± 720. 9) pg/ml. The single factor analysis illustrated that syncope(OR=26. 25,95%CI 3. 04 -226. 60,P=0. 003),heart func-tional class Ⅲ-Ⅳ(OR=19. 199,95%CI 1. 88 -196. 53, P=0. 0128), PASP≥70 mmHg(OR =9. 936, 95%CI 1. 81-∞,P=0. 005),BNP≥850 pg/ml(OR=59. 991,95%CI 4. 69-767. 62,P=0. 002) indica-ted the worse outcome. Conclusion IPAH in children is rare and the prognosis is poor. Syncope, cardiac function grade,PASP and the levels of BNP are the main important factors affecting the prognosis of children with IPAH. BNP has important clinical significance for the evaluation of IPAH and the prognosis of the disease.

Mortalidad por hipertensión arterial pulmonar idiopática en la Argentina / Mortality due to idiopathic pulmonary hypertension in Argentina / Mortalidade por hipertensão arterial pulmonar idiopática na Argentina

Objetivo. Describir la tasa de mortalidad anual por hipertensión arterial pulmonar idiopática (HAPI) en la República Argentina durante un lapso de diez años (2000-2009). Materiales y métodos. Se incluyeron todos los fallecimientos identificados con el número de registro I27.0 (CIE10) de la base de datos de la Dirección de Estadística e Información de Salud del Ministerio de Salud, Presidencia de la Nación, República Argentina. Los datos poblacionales fueron obtenidos del Instituto Nacional de Estadísticas y Censos de la República Argentina. Resultados. Entre los años 2000 y 2009 la tasa anual de mortalidad por HAPI en Argentina fue relativamente constante y osciló entre 1,39 y 2,39 muertes/1.000.000 habitantes. Fue más alta en las mujeres (1,76 a 3,16/1.000.000) que en los varones (0,9 a 2,11/1.000.000). El número más elevado de muertos por HAPI en los adultos se registró en el grupo de los mayores de 70 años. Las tasas de mortalidad más altas se encontraron en las provincias de Tierra del Fuego (31,42/1.000.000) y San Juan (17,61/1.000.000). Sin embargo, la superposición de los IC 95% de las tasas de mortalidad específica, ajustadas por edad y sexo, en el año 2009, sugiere que no hay diferencias significativas de mortalidad por HAPI entre las provincias. Conclusiones. En nuestro conocimiento éste es el primer estudio de las tasas de mortalidad por HAPI en la Argentina durante una década. La información obtenida puede servir de base para realizar, oportunamente, estudios más detallados de mortalidad específica. Parece necesario implementar un registro nacional de esta enfermedad para disponer de una información más confiable y poder promover la estandarización de las conductas diagnósticas y terapéuticas en todo el país, optimizando los recursos disponibles.

Objetive. To describe the annual mortality rate due to idiopathic pulmonary arterial hypertension (IPAH) in Argentina for a period of ten years (2000-2009). Materials and methods. The study included all I27.0 (ICD-10) coded deaths on the database of the Statistics and Health Information Board (Dirección de Estadística e Información de Salud: DEIS) of the Ministry of Health, National Presidency, Argentina. Population data were obtained from the National Institute of Statistics and Census (Instituto Nacional de Estadísticas y Censos: INDEC), Argentina. Results. Between 2000 and 2009 the IPAH annual mortality rate in Argentina was relatively constant and ranged between 1.39 and 2.39 deaths/1,000,000 inhabitants. It was higher in women (1.76 to 3.16/1,000,000) than in men (0.9 to 2.11/1,000,000). In adults, the highest number of IPAH deaths was recorded in the age group over 70 years. The highest mortality rates were recorded in the provinces of Tierra del Fuego (31.42/1,000,000) and San Juan (17.61/1,000,000). However, the overlap of the 95% of the specific mortality rates, adjusted for age and sex, in 2009, suggesting no significant difference in IPAH mortality between provinces. Conclusions. To our knowledge this is the first study of mortality rates from IPAH in Argentina for a period of 10 years. The information obtained can eventually become a basis for more detailed studies of specific mortality. It seems necessary to implement a national registry of this disease to provide more reliable information and to promote the standardization of diagnostic and therapeutic procedures nationwide, optimizing available resources.

Objetivo. Descrever a taxa de mortalidade anual devido à hipertensão arterial pulmonar idiopática (HAPI) na Argentina por um período de dez anos (2000-2009). Materiais e métodos. O estudo incluiu todos os óbitos identificados com o número de registro I27.0 (CID-10) da base de dados da Direção de Estatística e Informação em Saúde, Ministério da Saúde, Presidência da Nação, Argentina. Os dados populacionais foram obtidos do Instituto Nacional de Estatística e Censos (Instituto Nacional de Estadísticas y Censos: INDEC), Argentina. Resultados. Entre 2000 e 2009, a taxa anual de mortalidade por HAPI na Argentina foi relativamente constante e variou entre 1,39 e 2,39 mortes/1.000.000 de habitantes. Ela foi maior em mulheres (1,76-3,16/1.000.000) do que nos homens (0,9-2,11/1.000.000). Em adultos, o maior número de mortes por HAPI foi registrada na faixa etária acima de 70 anos. As maiores taxas de mortalidade foram registradas nas províncias de Tierra del Fuego (31,42/1.000.000) e San Juan (17,61/1.000.000). No entanto, a sobreposição de 95% das taxas de mortalidade específicas, ajustadas por idade e sexo, em 2009, sugerindo que não houve diferença significativa na mortalidade por HAPI entre as províncias. Conclusões. Para nosso conhecimento, este é o primeiro estudo de taxas de mortalidade por HAPI na Argentina por um período de 10 anos. A informação obtida pode eventualmente tornar-se uma base para estudos mais detalhados de mortalidade específica. Afigura-se necessário para implementar um registro nacional desta doença para fornecer informações mais seguras e para promover a padronização de procedimentos diagnósticos e terapêuticos em todo o país, otimizando os recursos disponíveis.

Hipertensão arterial pulmonar idiopática / Idiopathic pulmonar arterial hypertension

A hipertensão arterial pulmonar idiopática (HAPI) constitui o protótipo da hipertensão arterial pulmonar, fazendo parte da classificação clínica internacional de hipertensão pulmonar. O termo idiopático é reservado para a classificação da forma esporádica de hipertensão arterial pulmonar (HAP), desde que nenhuma causa aparente ou identificável esteja presente. A confirmação de caso de HAPI deve ser feito após extensa investigação diagnóstica. As outras condições que compõem o Grupo 1 compartilham com ela características histopatológicas e hemodinâmicas e constituem, como classe, o grupo mais avaliado quanto à eficácia e segurança dos medicamentos atualmente disponíveis para o seu tratamento...

Idiopathic pulmonary arterial hypertension (IPAH) is the prototype of pulmonary arterial hypertension syndrome, part of the international clinical classification of pulmonary hypertension. The term idiophatic is reserved for classification of the sporadic form of pulmonary arterial hypertension (PAH), provided that no apparent or identifiable cause is present. Confirmation of case HAPI should be done after extensive diagnostic investigation. The other conditions that make up the Group 1 share it with histopathologic and hemodynamic characteristics and are, as a class, the most evaluated group regarding the efficacy and safety of drugs currently available for its treatment...

Clinical Analysis in Patients of Idiopathic Pulmonary Hypertension With Acute Pulmonary Vasodilator Test / 中国循环杂志

Objective: To explore the effect of calcium channel blocker (CCB) treatment in patients of idiopathic pulmonary arterial hypertension (IPAH) with positive acute pulmonary vasodilator test, and to compare the hemodynamic differences between the positive and negative patients. Methods: A total of 156 consecutive IPAH patients with acute pulmonary vasodilator test were studied. The patients were divided into 2 groups according to the testing result. Positive group, n=23 and Negative group, n=133. The positive patients were followed up by clinical or telephone visit to investigate their CCB dose, WHO PAH cardiac classiifcation and the survival conditions. Kaplan-meier curve was conducted to analyze the living condition and t test was used to compare the hemodynamic differences between the positive and negative patients. Results: There were 43 male and 113 female patients at the male/female ratio of 1: 2.6, and 14.7% (23/156) positive patients. The average follow-up period for Positive group was (50.9 ± 3.8) months. There were 13 patients using diltiazem with the mean dose of (277 ± 108) mg/d at the range of (90-450) mg/d; 3 patients using amlodipine, 1 with the dose of 15mg/d and 2 with the dose of 7.5mg/d. The 1, 2 and 3 years survival rate for the positive patients were for 91.3%, 86.6% and 79.7% respectively. The mean pulmonary arterial pressure and pulmonary vascular resistance were lower, P=0.000, while the mixed venous oxygen saturation was higher in Positive group than Negative group, P=0.009.The NT-pro BNP level was lower in Positive group, P=0.001. Conclusion: IPAH patients has lower ratio of positive acute pulmonary vasodilator test. The positive patients has the higher 1, 3 and 5 years survival rate and better hemodynamic parameters as the mean pulmonary arterial pressure, pulmonary vascular resistance and better level of NT-pro BNP.

Epistatic interactions in idiopathic pulmonary arterial hypertension.

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a poorly understood complex disorder, which results in progressive remodeling of the pulmonary artery that ultimately leads to right ventricular failure. A two-hit hypothesis has been implicated in pathogenesis of IPAH, according to which the vascular abnormalities characteristic of PAH are triggered by the accumulation of genetic and/or environmental insults in an already existing genetic background. The multifactor dimensionality reduction (MDR) analysis is a statistical method used to identify gene–gene interaction or epistasis and gene–environment interactions that are associated with a particular disease. The MDR method collapses high-dimensional genetic data into a single dimension, thus permitting interactions to be detected in relatively small sample sizes. AIM: To identify and characterize polymorphisms/genes that increases the susceptibility to IPAH using MDR analysis. MATERIALS AND METHODS: A total of 77 IPAH patients and 100 controls were genotyped for eight polymorphisms of five genes (5HTT, EDN1, NOS3, ALK-1, and PPAR-γ2). MDR method was adopted to determine gene–gene interactions that increase the risk of IPAH. RESULTS: With MDR method, the single-locus model of 5HTT (L/S) polymorphism and the combination of 5HTT(L/S), EDN1(K198N), and NOS3(G894T) polymorphisms in the three-locus model were attributed to be the best models for predicting susceptibility to IPAH, with a P value of 0.05. CONCLUSION: MDR method can be useful in understanding the role of epistatic and gene–environmental interactions in pathogenesis of IPAH.

Interpretación de la relación presión-flujo en la hipertensión arterial pulmonar idiopática / Pressure-flow relationships interpretation in idiopathic pulmonary arterial hypertension

Objetivo: Conocer más de la relación presión arterial pulmonar media/índice cardiaco y sus perfiles en enfermos con hipertensión arterial pulmonar idiopática. Métodos: La presión arterial pulmonar media/índice cardiaco y la presión extrapolada al eje de cero flujo se obtuvo en 40 enfermos respirando aire ambiente, oxígeno 99.5% e hidralazina. Se obtuvieron dos grupos de acuerdo a criterios de "respuesta vasodilatadora aguda", respondedores (n = 20) y no respondedores (n = 20). Se analizó este criterio versus el propuesto por la Task Force de la Sociedad Europea de Cardiología en la población respondedora. Resultados: La presión arterial pulmonar media/Índice cardiaco se ubicó de forma anormal en el diagrama de presión-flujo de la cohorte total, (p < 0.01). Sin alteraciones en el intercambio gaseoso o mecánica pulmonar. Para los enfermos respondedores versus no respondedores, la pendiente fue anormal 2.2 (95%IC:1.1-3.3) vs. 5.89 (95%IC:4.69-7.11) mm Hg/L min/m² e incremento de la presión extrapolada al eje de cero flujo (38.2 ± 7.5 a 66.3 ± 7.5 mm Hg, p < 0.01). Sin diferencias con oxígeno al 99.5%. Con vasodilatador, la presión arterial pulmonar media disminuyó (52.1 ± 9.5 a 40 ± 5.5 mm Hg, p < 0.01) vs. no se modificó (96.2 ± 8.5 vs. 90 ± 7.5 mmHg, p = 0.3), pendiente 1.15 (95%IC:0.68-1.62) vs. 1.28 (95%IC:0.78-1.78) mmHg/Lmin/m², la presión extrapolada al eje de cero flujo no cambió vs. incrementó (69.4 ± 7.8 a 85.1 ± 8.5 mm Hg, p < 0.01), en relación al control. En no respondedores con vasodilatador, la presión arterial pulmonar media/índice cardiaco (90 ± 7.5 mmHg, pendiente:1.28; 95%IC: 0.78 - 1.78 mm Hg/L min/m²) fue diferente al comparar respondedores con menor o mayor de 40 mm Hg de presión arterial pulmonar media. Presiones 34 ± 3 vs. 45 ± 4 mm Hg y pendientes 1.14 (95%IC: 0.67 -1.61 vs. 2.22 (95%IC: 1.35 - 3.09 mm Hg/L min/m²), respectivamente p < 0.01. Conclusiones: Las anormalidades de la relación presión arterial pulmonar media/Índice cardiaco reflejan el incremento de las resistencias vasculares pulmonares reales a nivel arteriolar pulmonar en enfermos con hipertensión arterial pulmonar idiopática. Ambos criterios de respuesta vasodilatadora aguda son de utilidad para identificar respondedores y no, en esta población de enfermos.

Objectives: We analyze exercise-derived mean pulmonary artery pressure/cardiac index relationship to expand the concepts regarding its nature and to better identify "responders" in idiopathic pulmonary arterial hypertension patients. Methods: Mean pulmonary artery pressure/cardiac index relationship and extrapolated pressure to zero flow were obtained in 40 patients' breathing room air, oxygen 99.5% and hydralazine. The hemodynamic characteristics were analyzed for the cohort and separate for responders (n = 20) and non responders (n = 20) according to the acute response to vasodilator. We tested this previous criteria versus the Task Force on diagnosis and treatment prescribed by the European Society of Cardiology. Results: The mean pulmonary arterial pressure/cardiac index was located abnormally in the pressure-flow diagram of the total cohort (p < 0.01). No alterations in gas exchange or lung mechanics. For patients responders versus non-responders, the slope was abnormal 2.2 (95% CI:1.1-3.3) vs. 5.89 (95% CI: 4.69 - 7.11), mm Hg/L min/m² and increased extrapolated pressure to zero flow (38.2 ± 7.5 to 66.3 ± 7.5 mm Hg, p <0.01). Without difference with oxygen 99.5%. With vasodilator effect, mean pulmonary arterial pressure decreased (52.1 ± 9.5 to 40 ± 5.5 mm Hg, p <0.01) versus it did not change (96.2 ± 8.5 versus 90 ± 7.5 mm Hg, p=0.3), slope 1.15 (95% CI: 0.68 - 1.62) vs. 1.28 (95% CI: 0.78-1.78) mmHg/L min/m², the extrapolated pressure to zero flow did not change (69.4 ± 7.8 to 85.1 ± 8.5 mm Hg), p <0.01, compared to control. In non-responders with vasodilator, mean pulmonary arterial pressure/cardiac index (90 ± 7.5 mmHg, slope: 1.28, 95% CI :0.78 - 1.78 mm Hg/L min/m²) was different between responders < or > 40 mmHg mean pulmonary arterial pressure. Pressures were 34 ± 3 vs. 45 ± 4 mm Hg and slopes 1.14 (95% CI: 0.67 - 1.61) vs. 2.22(95% CI: 1.35 - 3.09) mm Hg/L min/m², p <0.01, respectively.. Conclusions: Abnormalities of the mean pulmonary arterial pressure/cardiac index relationship exercise-derived seems to reflect "mainly arteriolar" increased lineal pulmonary vascular resistance in idiopathic pulmonary arterial hypertension patients. Both acute vasodilator response criteria are useful to identify responders and not responders in this patient population.

Hipertensão arterial pulmonar idiopática manifestada durante a gestação: correlação anátomo-clínica com necropsia. Relato de caso / Idiopathic pulmonary arterial hypertension manifested during pregnancy: anatomical-clinical correlation with necropsy. Case report

JUSTIFICATIVA E OBJETIVOS: A hipertensão arterial pulmonar idiopática (HAPI) é uma entidade rara, com prevalência estimada em 1-2 casos por milhão de pessoas. Sua relação com a gestação é relatada na literatura com freqüência de 4,5% em pacientes com HAPI. O objetivo deste estudo foi demonstrar um caso de HAPI relacionado com a gravidez, de evolução prolongada, a discordância entre o grau de lesão das artérias de pequeno calibre na anatomia patológica e a medida da pressão da artéria pulmonar no ecocardiograma. RELATO DO CASO: Paciente com 33 anos, branca, em sua segunda gestação, iniciou com quadro de dispnéia e edema nos membros inferiores, intensificados ao final do segundo trimestre, sendo realizada cesariana eletiva. Manteve os sintomas por dois meses. Referiu também dor precordial no hipocôndrio direito em sua segunda internação. Ao exame físico, observou-se estase jugular e hepatomegalia dolorosa, à ausculta cardíaca observou-se ritmo de galope protodiastólico, hiperfonese de segunda bulha em focos da base e sopro holossistólico em foco tricúspide. A investigação complementar confirmou a origem idiopática da doença. O óbito ocorreu por choque cardiogênico. CONCLUSÕES: A observação clínica indicou o diagnóstico de HAPI, afastando outras causas de hipertensão pulmonar. À necropsia, o diagnóstico pôde ser reforçado e foram afastadas outras causas específicas de hipertensão pulmonar na gestação. Apesar de não ter sido realizado estudo hemodinâmico, a pressão média da artéria pulmonar estimada pelo exame ultra-sonográfico foi discordante com a magnitude das lesões nas artérias de pequeno calibre detectadas no exame histopatológico. A HAPI durante a gestação possui elevada mortalidade e trata-se de uma doença ainda sem cura e com muitos aspectos fisiopatológicos a serem esclarecidos. As medidas de maior impacto continuam sendo a prevenção na gestação; e, se esta ocorrer, recomenda-se a sua interrupção precoce.(AU)

BACKGROUND AND OBJECTIVES: Idiopathic pulmonary arterial hypertension (IPAH) is a rare entity, with prevalence estimated in 1-2 cases/1.000.000. Its relationship with pregnancy, in the literature, is reported a 4.5% rate of patients with IPAH. The objective of this study was to demonstrate a case of IPAH related to pregnancy with extended evolution and the discord between the injury degree of the small bore arteries in the pathological anatomy and the measure of pulmonary artery pressure in echocardiography. CASE REPORT: Patient, 33 years-old, white, in her second pregnancy, initiated with symptoms of dyspnea and peripheral edema, intensified in the end of the second trimester, been realized cesarean section. She kept the symptoms for two months and related precordial and right hypochondriac pain in her second hospitalization. On physical examination, there were elevated jugular venous pressure and painful enlarged liver. On auscultation, there were gallop rhythm, prominent aortic and pulmonary second heart sounds and tricuspid pansystolic murmur. The complementary investigation confirmed the idiopathic origin of the disease. The death occurred due cardiogenic shock. CONCLUSION: The clinical observation indicates the diagnosis of IPAH, excluding other causes of pulmonary hypertension. In the necropsy, the diagnosis could have been confirmed and other specific causes of pulmonary hypertension in pregnancy could have been excluded. Although right heart catheterization haven’t been realized, the pulmonary artery pressure determined by echocardiography is discordant of the magnitude of the injuries in the small bore arteries detected in the microscopic examination. IPAH during pregnancy has great mortality and is an illness still without cure and with many physiopathological aspects to be revealed. The pregnancy prevention is recommended, if the pregnancy occurs, precocious interruption of the same one must be realized.(AU)

t-plasminogen activator inhibitor-1 polymorphism in idiopathic pulmonary arterial hypertension.

AIM: The aim of the present study was to identify the possible genotypic association of 3’UTR Hind III polymorphism of Plasminogen activator Inhibitor-1 (PAI-1) gene with idiopathic pulmonary arterial hypertension (IPAH). BACKGROUND: IPAH is a disorder with abnormally raised mean pulmonary arterial pressure and increase in the resistance to blood flow in pulmonary artery. One of the pathological features seen is development of intraluminal thrombin deposition leading to thrombosis. Plasminogen activator inhibitor-1 is an important inhibitor of the fibrinolytic system; its up-regulation may suppress fibrinolysis and result in an increased risk of thrombosis. METHOD: Blood samples from 54 IPAH patients and 100 healthy voluntary donors were analyzed by PCR-RFLP method for 3’UTR Hind III polymorphism. RESULTS AND DISSCUSSION: A significant association of Hd2 allele with the disease was observed. Raised mean level of right ventricular systolic pressure was observed in the Hd2/Hd2 genotypic patients, strengthening the role of Hd2 allele in the disease progression. Our data suggests an association of Hd2/Hd2 genotype, which may lead to the up-regulation of PAI-1 gene leading to increased levels of PAI-1, which is seen in IPAH. PAI-1 competes with plasminogen activators and hinders the normal mechanism of plasminogen activation system and leads to thrombosis and formation of plexiform lesions in the lung tissue, further strengthening its role in tissue remodeling and disease progression.

Comparison of Clinical Features between Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension / 결핵및호흡기질환

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are rare but significantly imperative in inducing chronic pulmonary hypertension. Clinically, it is difficult to distinguish between IPAH and CTEPH. However, the treatment of pulmonary hypertension is different depending on the disease. The present study was performed to analyze the similarities and differences in clinical features between IPAH and CTEPH. METHODS: During a nine-year period, thirty-three patients with IPAH and twenty-two patients with CTEPH were enrolled. Symptoms, physical findings, chest radiograph, electrocardiograph, pulmonary function test, echocardiograph, perfusion lung scan, right heart catheterization results were analyzed between both the groups. RESULTS: The median age of IPAH group was 33 (6~70) years that was lower than that (52(27~80) years) of CTEPH group. Amongst the IPAH patients, there was female predominance (76 %) and there was no sex difference between the patients with CTEPH. Both the groups exhibited similarity in the results of chest radiograph, electrocardiograph, pulmonary function test, and echocardiograph. In the perfusion lung scan, all IPAH patients exhibited findings with normal (28%) or low probability (72%) of pulmonary embolism and all CTEPH patients exhibited findings with high probability of pulmonary embolism. CONCLUSION: Although IPAH and CTEPH bear similarities in terms of symptoms, physical signs and general investigation results, there were differences in age distribution, sex predominance and results of perfusion lung scan.